Structure-based investigation of rat aldehyde oxidase inhibition by flavonoids

References

• Allinger NL. (1977). Conformational analysis 130. MM2. A hydrocarbon force field utilizing v1 and v2 torsional terms. J Am Chem Soc 99:8127–34
   Web of Science ®Google Scholar
• Arora A, Nair MG, Strasburg GM. (1998). Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med 24:1355–63
   PubMed Web of Science ®Google Scholar
• Beedham C, Miceli JJ, Obach RS. (2003). Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J Clin Psychopharmacol 23:229–32
   PubMed Web of Science ®Google Scholar
• Cermak R. (2008). Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol 4:17–35
   PubMed Web of Science ®Google Scholar
• Cos P, Ying L, Calomme M, et al. (1998). Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 61:71–6
   PubMed Web of Science ®Google Scholar
• Dastmalchi S, Hamzeh-Mivehrod M. (2005). Molecular modelling of human aldehyde oxidase and identification of the key interactions in the enzyme-substrate complex. Daru 13:82–93
   Google Scholar
• Dewar MJS, Thiel W. (1977). Ground states of molecules.39.MNDO results for molecules containing hydrogen, carbon, nitrogen and oxygen. J Am Chem Soc 99:4907–17
   Web of Science ®Google Scholar
• Erlund I, Meririnne E, Alfthan G, et al. (2001). Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131:235–41
   PubMed Web of Science ®Google Scholar
• Garattini E, Mendel R, Romao MJ, et al. (2003). Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochem J 372:15–32
   PubMed Web of Science ®Google Scholar
• Garattini E, Terao M. (2011). Increasing recognition of the importance of aldehyde oxidase in drug development and discovery. Drug Metab Rev 43:374–86
   PubMed Web of Science ®Google Scholar
• Garattini E, Terao M. (2012). The role of aldehyde oxidase in drug metabolism. Expert Opin Drug Metab Toxicol 8:487–503
   PubMed Web of Science ®Google Scholar
• Haidari F, Rashidi MR, Keshavarz SA, et al. (2008). Effects of onion on serum uric acid levels and hepatic xanthine dehydrogenase/xanthine oxidase activities in hyperuricemic rats. Pak J Biol Sci 11:1779–84
   PubMedGoogle Scholar
• Hayashi T, Sawa K, Kawasaki M, et al. (1988). Inhibition of cow’s milk xanthine oxidase by flavonoids. J Nat Prod 51:345–8
   PubMed Web of Science ®Google Scholar
• Hodnett CN, McCormack JJ, Sabean JA. (1976). Oxidation of selected pteridine derivatives by mammalian liver xanthine oxidase and aldehyde oxidase. J Pharm Sci 65:1150–4
   PubMed Web of Science ®Google Scholar
• Hoffman PL, Wermuth B, von Wartburg JP. (1980). Multiple aldehyde reductases of human brain. Adv Exp Med Biol 132:749–59
   PubMedGoogle Scholar
• Jaganath IB, Crozier A. (2010). Dietary flavonoids and phenolic compounds. In: Fraga CG, ed. Plant phenolics and human health. New Jersey: Wiley, 1–49
   Google Scholar
• Johns DG. (1967). Human liver aldehyde oxidase: differential inhibition of oxidation of charged and uncharged substrates. J Clin Invest 46:1492–505
   PubMed Web of Science ®Google Scholar
• Johnson C, Stubley-Beedham C, Stell JG. (1985). Hydralazine: a potent inhibitor of aldehyde oxidase activity in vitro and in vivo. Biochem Pharmacol 34:4251–6
   PubMed Web of Science ®Google Scholar
• Jordan CG, Rashidi MR, Laljee H, et al. (1999). Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man. J Pharm Pharmacol 51:411–18
   PubMed Web of Science ®Google Scholar
• Kitamura S, Nakatani K, Sugihara K, et al. (1999). Strain differences of the ability to hydroxylate methotrexate in rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 122:331–6
   PubMed Web of Science ®Google Scholar
• Kitamura S, Ohashi KNK, Sugihara K, et al. (2001). Extremely high drug-reductase activity based on aldehyde oxidase in monkey liver. Biol Pharm Bull 24:856–9
   PubMed Web of Science ®Google Scholar
• Lake BG, Ball SE, Kao J, et al. (2002). Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase. Xenobiotica 32:835–47
   PubMed Web of Science ®Google Scholar
• Le Bail JC, Laroche T, Marre-Fournier F, et al. (1998). Aromatase and 17beta-hydroxysteroid dehydrogenase inhibition by flavonoids. Cancer Lett 133:101–6
   PubMed Web of Science ®Google Scholar
• Leardi R. (2000). Application of genetic algorithm-PLS for feature selection in spectral data sets. J Chemomet 14:643–55
   Web of Science ®Google Scholar
• Lin CM, Chen CS, Chen CT, et al. (2002). Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem Biophys Res Commun 294:167–72
   PubMed Web of Science ®Google Scholar
• Mendel RR, Bittner F. (2006). Cell biology of molybdenum. Biochim Biophys Acta 1763:621–35
   PubMed Web of Science ®Google Scholar
• Metodiewa D, Kochman A, Karolczak S. (1997). Evidence for antiradical and antioxidant properties of four biologically active N,N-diethylaminoethyl ethers of flavanone oximes: a comparison with natural polyphenolic flavonoid (rutin) action. Biochem Mol Biol Int 41:1067–75
   PubMedGoogle Scholar
• Mo SF, Zhou F, Lv YZ, et al. (2007). Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Biol Pharm Bull 30:1551–6
   PubMed Web of Science ®Google Scholar
• Mooij WT, Verdonk ML. (2005). General and targeted statistical potentials for protein-ligand interactions. Proteins 61:272–87
   PubMed Web of Science ®Google Scholar
• Nagao A, Seki M, Kobayashi H. (1999). Inhibition of xanthine oxidase by flavonoids. Biosci Biotechnol Biochem 63:1787–90
   PubMed Web of Science ®Google Scholar
• Obach RS, Huynh P, Allen MC, et al. (2004). Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol 44:7–19
   PubMed Web of Science ®Google Scholar
• Okamoto K, Matsumoto K, Hille R, et al. (2004). The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition. Proc Natl Acad Sci USA 101:7931–6
   PubMed Web of Science ®Google Scholar
• Pirouzpanah S, Hanaee J, Razavieh SV, et al. (2009). Inhibitory effects of flavonoids on aldehyde oxidase activity. J Enzyme Inhib Med Chem 24:14–21
   PubMed Web of Science ®Google Scholar
• Pirouzpanah S, Rashidi MR, Delazar A, et al. (2006). Inhibitory effects of Ruta graveolens L. extract on guinea pig liver aldehyde oxidase. Chem Pharm Bull (Tokyo) 54:9–13
   PubMed Web of Science ®Google Scholar
• Ponce AM, Blanco SE, Molina AS, et al. (2000). Study of the action of flavonoids on xanthine-oxidase by molecular topology. J Chem Inf Comput Sci 40:1039–45
   PubMedGoogle Scholar
• Pryde DC, Dalvie D, Hu Q, et al. (2010). Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem 53:8441–60
   PubMed Web of Science ®Google Scholar
• Rashidi MR, Nazemiyeh H. (2010). Inhibitory effects of flavonoids on molybdenum hydroxylases activity. Expert Opin Drug Metab Toxicol 6:133–52
   PubMed Web of Science ®Google Scholar
• Rashidi MR, Smith JA, Clarke SE, et al. (1997). In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. Drug Metab Dispos 25:805–13
   PubMed Web of Science ®Google Scholar
• Schuur J, Gasteiger J. (1997). Infrared spectra simulation of substituted benzene derivatives on the basis of a 3D structure representation. Anal Chem 69:2398–405
   PubMedGoogle Scholar
• Schuur JH, Selzer P, Gasteiger J. (1996). The coding of the three-dimensional structure of molecules by molecular transforms and its application to structure-spectra correlations and studies of biological activity. J Chem Inf Comput Sci 36:334–44
   Google Scholar
• Sugihara K, Katsuma Y, Tanaka C, et al. (1999). Purification and some properties of hamster liver aldehyde oxidase. Biol Pharm Bull 22:1246–8
   PubMedGoogle Scholar
• Tayama Y, Sugihara K, Sanoh S, et al. (2011). Effect of tea beverages on aldehyde oxidase activity. Drug Metab Pharmacokinet 26:94–101
   PubMed Web of Science ®Google Scholar
• Todeschini R, Gramatica P. (1997). SD-modelling and prediction by WHIM descriptors. Part 5. Theory development and chemical meaning of WHIM descriptors. Quant Struct Act Relat 16:113–16
   Google Scholar
• Ueda O, Kitamura S, Ohashi K, et al. (2003). Xanthine oxidase-catalyzed metabolism of 2-nitrofluorene, a carcinogenic air pollutant, in rat skin. Drug Metab Dispos 31:367–72
   PubMed Web of Science ®Google Scholar
• van Hoorn DE, Nijveldt RJ, van Leeuwen PA, et al. (2002). Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 451:111–18
   PubMed Web of Science ®Google Scholar
• Walker EH, Pacold ME, Perisic O, et al. (2000). Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6:909–19
   PubMed Web of Science ®Google Scholar
• Wang HR, Zhu WJ, Wang XY. (2011). Mechanism of inhibition of arginine kinase by flavonoids consistent with thermodynamics of docking simulation. Int J Biol Macromol 49:985–91
   PubMedGoogle Scholar
• Wattenberg LW, Page MA, Leong JL. (1968). Induction of increased benzpyrene hydroxylase activity by flavones and related compounds. Cancer Res 28:934–7
   PubMed Web of Science ®Google Scholar
• Xiao ZP, Wang XD, Peng ZY, et al. (2012). Molecular docking, kinetics study, and structure-activity relationship analysis of quercetin and its analogous as helicobacter pylori urease inhibitors. J Agric Food Chem 60:10572–7
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Matsumura T, Ichida K, et al. (2007). Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate. J Biochem 141:513–24
   PubMed Web of Science ®Google Scholar
• Yoshihara S, Ohta S. (1998). Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone. Arch Biochem Biophys 360:93–8
   PubMed Web of Science ®Google Scholar
• Yoshino S, Hara A, Sakakibara H, et al. (2011). Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria. Nutrition 27:847–52
   PubMed Web of Science ®Google Scholar
• Zhu JX, Wang Y, Kong LD, et al. (2004). Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and XDH and xanthine oxidase activities in mouse liver. J Ethnopharmacol 93:133–40
   PubMed Web of Science ®Google Scholar